-transparent.png){kind=logo}
Forty patients with metastatic breast cancer were treated with a combination of continuous 5-day infusion vinblastine and peptichemio. All patients had received prior therapy with 5-fluorouracil, adriamycin, cyclophosphamide and methotrexate. Vinblastine was given at a dose of 1.2 mg/m2/day for 5 days. Following completion of the 5-day infusion vinblastine, peptichemio was given as a rapid I.V. injection at a dose of 60 mg/m2. Ten partial responses (30%) were observed among the 33 evaluable patients with a median time to treatment failure of 6 months. Myelosuppression, predominantly granulocytopenia, was the major toxicity resulting from this combination. The response rate of this combination is not better than that observed with continuous 5-day infusion vinblastine alone.
H Y Yap, and
G R Blumenschein, and
G N Hortobagyi, and
A U Buzdar, and
F C Schell, and
G P Bodey
August 1988,
American journal of clinical oncology,
H Y Yap, and
G R Blumenschein, and
G N Hortobagyi, and
A U Buzdar, and
F C Schell, and
G P Bodey
November 1987,
Cancer treatment reports,
H Y Yap, and
G R Blumenschein, and
G N Hortobagyi, and
A U Buzdar, and
F C Schell, and
G P Bodey
January 1991,
Chemotherapy,
H Y Yap, and
G R Blumenschein, and
G N Hortobagyi, and
A U Buzdar, and
F C Schell, and
G P Bodey
May 1984,
Cancer,
H Y Yap, and
G R Blumenschein, and
G N Hortobagyi, and
A U Buzdar, and
F C Schell, and
G P Bodey
August 2000,
Annals of oncology : official journal of the European Society for Medical Oncology,
H Y Yap, and
G R Blumenschein, and
G N Hortobagyi, and
A U Buzdar, and
F C Schell, and
G P Bodey
September 1986,
Cancer,
H Y Yap, and
G R Blumenschein, and
G N Hortobagyi, and
A U Buzdar, and
F C Schell, and
G P Bodey
January 1985,
Cancer treatment reports,
H Y Yap, and
G R Blumenschein, and
G N Hortobagyi, and
A U Buzdar, and
F C Schell, and
G P Bodey
September 1981,
Cancer,
H Y Yap, and
G R Blumenschein, and
G N Hortobagyi, and
A U Buzdar, and
F C Schell, and
G P Bodey
May 1984,
Cancer treatment reports,
H Y Yap, and
G R Blumenschein, and
G N Hortobagyi, and
A U Buzdar, and
F C Schell, and
G P Bodey
August 1997,
The Journal of urology,
